par Rothé, Françoise
;Laes, J F;Lambrechts, Diether;Smeets, D;Vincent, D.;Maetens, Marion M.
;Fumagalli, Debora
;Michiels, Stefan
;Drisis, Stylianos
;Moerman, C;Detiffe, J-P;Larsimont, Denis
;Awada, Ahmad
;Piccart-Gebhart, Martine
;Sotiriou, Christos
;Ignatiadis, Michail 
Référence Annals of oncology, 25, 10, page (1959-1965)
Publication Publié, 2014-10
;Laes, J F;Lambrechts, Diether;Smeets, D;Vincent, D.;Maetens, Marion M.
;Fumagalli, Debora
;Michiels, Stefan
;Drisis, Stylianos
;Moerman, C;Detiffe, J-P;Larsimont, Denis
;Awada, Ahmad
;Piccart-Gebhart, Martine
;Sotiriou, Christos
;Ignatiadis, Michail 
Référence Annals of oncology, 25, 10, page (1959-1965)
Publication Publié, 2014-10
Article révisé par les pairs
| Résumé : | Molecular screening programs use next-generation sequencing (NGS) of cancer gene panels to analyze metastatic biopsies. We interrogated whether plasma could be used as an alternative to metastatic biopsies. |



